Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Therapeutics, Inc. - Common Stock (NQ: APLT )

0.6470 +0.0543 (+9.16%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Applied Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Investors
From Law Offices of Howard G. Smith
Via Business Wire
Law Offices of Frank R. Cruz Encourages Applied Therapeutics, Inc. (APLT) Investors To Inquire About Securities Fraud Class Action
From The Law Offices of Frank R. Cruz
Via Business Wire
Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who Purchased Common Stock of Applied Therapeutics, Inc. (NASDAQ: APLT)
Via TheNewswire.com
This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
Via Benzinga
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Class Action Announcement (APLT): A Securities Fraud Class Action Lawsuit Was Filed Against Applied Therapeutics, Inc.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who Purchased Common Stock of Applied Therapeutics, Inc. (NASDAQ: APLT)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
APPLIED THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Faruqi & Faruqi Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 – APLT
From Faruqi & Faruqi LLP
Via GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Reminds APLT Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc. (APLT)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
APLT DEADLINE FOR LEADERSHIP is February 18, 2025 in a Securities Fraud Lawsuit - Contact Kaplan Fox
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
APPLIED THERAPEUTICS DEADLINE FOR LEADERSHIP is February 18, 2025 in a Securities Fraud Lawsuit - Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
APLT Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc.
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
APLT Investor Alert: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Applied Therapeutics, Inc.
From Robbins LLP
Via GlobeNewswire
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before February 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
APLT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
NEW YORK - (NewMediaWire) - December 21, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the... 
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data
Adrian Alexandru files a securities lawsuit against Applied Therapeutics, alleging the company misled investors about clinical trials for govorestat. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal Product Safety
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 18, 2025
NEW YORK - (NewMediaWire) - December 20, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the... 
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Applied Therapeutics Appoints John H. Johnson as Executive Chairman
From Applied Therapeutics
Via GlobeNewswire
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
An Investigation Has Commenced on Behalf of Applied Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your APLT Losses
Via ACCESSWIRE
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about Securities Fraud Investigation - APLT
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.